CIK: 0001493215 · Show all filings
Period: Q4 2025 (← Previous)
Filing Date: Feb 17, 2026
Total Value ($000): $9,983,317 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| IRTC | IRHYTHM TECHNOLOGIES INC | 1,181,990 | $209,732 | 2.1% | $177.21 | 0.0% | COM | 450056106 |
| APLS | APELLIS PHARMACEUTICALS INC | 7,666,764 | $192,589 | 1.9% | $23.46 | 0.0% | COM | 03753U106 |
| RGEN | REPLIGEN CORP | 1,064,000 | $174,347 | 1.7% | $156.63 | 0.0% | COM | 759916109 |
| PODD | INSULET CORP | 324,600 | $92,264 | 0.9% | $312.66 | 0.0% | COM | 45784P101 |
| CSTL | CASTLE BIOSCIENCES INC | 2,115,237 | $82,283 | 0.8% | $32.24 | 0.0% | COM | 14843C105 |
| IMVT | IMMUNOVANT INC | 3,177,850 | $80,781 | 0.8% | $22.30 | 0.0% | COM | 45258J102 |
| CELC | CELCUITY INC | 550,160 | $54,873 | 0.5% | $82.21 | 0.0% | COM | 15102K100 |
| KOD | KODIAK SCIENCES INC | 1,487,933 | $41,603 | 0.4% | $20.48 | 0.0% | COM | 50015M109 |
| ARWR | ARROWHEAD PHARMACEUTICALS IN | 584,716 | $38,819 | 0.4% | $49.01 | 0.0% | COM | 04280A100 |
| SVRA | SAVARA INC | 5,952,380 | $35,893 | 0.4% | $4.90 | 0.0% | COM | 805111101 |
| EVMN | EVOMMUNE INC | 1,283,671 | $21,976 | 0.2% | $18.78 | 0.0% | COM SHS | 30054Y107 |
| KYMR | KYMERA THERAPEUTICS INC | 240,000 | $18,674 | 0.2% | $67.53 | 0.0% | COM | 501575104 |
| FLGT | FULGENT GENETICS INC | 705,027 | $18,521 | 0.2% | $25.94 | 0.0% | COM | 359664109 |
| HNGE | HINGE HEALTH INC | 353,500 | $16,420 | 0.2% | $48.16 | 0.0% | CL A | 433313103 |
| BEAM | BEAM THERAPEUTICS INC | 570,394 | $15,811 | 0.2% | $25.51 | 0.0% | COM | 07373V105 |
| TNGX | TANGO THERAPEUTICS INC | 1,491,228 | $13,212 | 0.1% | $8.62 | 0.0% | COM | 87583X109 |
| LMRI | LUMEXA IMAGING HOLDINGS INC | 650,000 | $12,025 | 0.1% | $18.05 | 0.0% | COM | 550249106 |
| KLRS | KALARIS THERAPEUTICS INC | 1,300,000 | $10,972 | 0.1% | $6.39 | 0.0% | COM | 482929106 |
| IQV | IQVIA HLDGS INC | 46,000 | $10,369 | 0.1% | $217.58 | 0.0% | COM | 46266C105 |
| — | ATAI BECKLEY NV | 2,000,000 | $8,180 | 0.1% | $4.09 | — | SHS | N0731H103 |
| CAPR | CAPRICOR THERAPEUTICS INC | 250,000 | $7,215 | 0.1% | $13.06 | 0.0% | COM NEW | 14070B309 |
| GPCR | STRUCTURE THERAPEUTICS INC | 100,000 | $6,955 | 0.1% | $69.55 | — | SPONSORED ADS | 86366E106 |
| IVA | INVENTIVA SA | 1,298,701 | $6,039 | 0.1% | $4.65 | — | ADS | 46124U107 |
| CBIO | CRESCENT BIOPHARMA INC. | 372,856 | $4,422 | 0.0% | $12.74 | 0.0% | COM | G2545C104 |
| — | MIND MEDICINE MINDMED INC | 300,000 | $4,017 | 0.0% | $13.39 | — | COM NEW | 60255C885 |
| FDMT | 4D MOLECULAR THERAPEUTICS IN | 475,737 | $3,568 | 0.0% | $10.14 | 0.0% | COM | 35104E100 |
| MDLN | MEDLINE INC | 70,000 | $2,940 | 0.0% | $42.23 | 0.0% | COM CL A | 58507V107 |
| IRON | DISC MEDICINE INC | 30,000 | $2,382 | 0.0% | $84.50 | 0.0% | COM | 254604101 |
| ERAS | ERASCA INC | 146,651 | $546 | 0.0% | $2.81 | 0.0% | COM | 29479A108 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| INSM | INSMED INC | 4,842,879 (+57.0%) | $842,855 (+89.7%) | 8.4% | $85.76 | +112.8% | COM PAR $.01 | 457669307 |
| COGT | COGENT BIOSCIENCES INC | 7,592,241 (+119.0%) | $269,676 (+441.6%) | 2.7% | $20.68 | +35.9% | COM | 19240Q201 |
| BLTE | BELITE BIO INC | 715,332 (+128.9%) | $114,425 (+394.8%) | 1.1% | $122.41 | — | SPONSORED ADS | 07782B104 |
| TARS | TARSUS PHARMACEUTICALS INC | 3,335,320 (+5.0%) | $273,096 (+44.6%) | 2.7% | $28.29 | +164.0% | COM | 87650L103 |
| SYRE | SPYRE THERAPEUTICS INC | 4,171,996 (+15.2%) | $136,675 (+125.1%) | 1.4% | $21.67 | +20.6% | COM NEW | 00773J202 |
| RDNT | RADNET INC | 3,938,500 (+39.9%) | $281,012 (+31.0%) | 2.8% | $55.16 | +40.0% | COM | 750491102 |
| STOK | STOKE THERAPEUTICS INC | 5,546,856 (+8.3%) | $176,057 (+46.2%) | 1.8% | $22.80 | +31.8% | COM | 86150R107 |
| ZLAB | ZAI LAB LTD | 6,959,032 (+203.7%) | $122,757 (+58.1%) | 1.2% | $22.08 | — | ADR | 98887Q104 |
| IMTX | IMMATICS N.V | 11,433,354 (+29.7%) | $120,050 (+59.8%) | 1.2% | $10.05 | +0.4% | SHS | N44445109 |
| REPL | REPLIMUNE GROUP INC | 7,140,352 (+11.6%) | $69,404 (+159.0%) | 0.7% | $7.45 | +14.1% | COM | 76029N106 |
| XNCR | XENCOR INC | 6,777,461 (+8.9%) | $103,763 (+42.2%) | 1.0% | $13.91 | +7.4% | COM | 98401F105 |
| CRNX | CRINETICS PHARMACEUTICALS IN | 1,351,326 (+54.9%) | $62,904 (+73.1%) | 0.6% | $36.04 | +23.5% | COM | 22663K107 |
| ORKA | ORUKA THERAPEUTICS INC | 2,058,148 (+5.8%) | $62,382 (+66.7%) | 0.6% | $33.93 | -17.9% | COM | 687604108 |
| RAPT | RAPT THERAPEUTICS INC | 1,637,165 (+11.3%) | $55,451 (+46.2%) | 0.6% | $10.01 | +210.1% | COM NEW | 75382E208 |
| WVE | WAVE LIFE SCIENCES LTD | 1,350,000 (+50.0%) | $22,950 (+248.4%) | 0.2% | $7.37 | +37.8% | SHS | Y95308105 |
| CGON | CG ONCOLOGY INC | 2,012,127 (+18.3%) | $83,544 (+21.9%) | 0.8% | $36.89 | +12.2% | COM | 156944100 |
| GHRS | GH RESEARCH PLC | 5,933,815 (+6.5%) | $75,359 (-5.4%) | 0.8% | $14.83 | -8.1% | ORDINARY SHARES | G3855L106 |
| VSTM | VERASTEM INC | 6,576,306 (+21.2%) | $50,769 (+6.0%) | 0.5% | $6.84 | +30.3% | COM NEW | 92337C203 |
| ALUR | ALLURION TECHNOLOGIES INC | 5,891,430 (+131.7%) | $7,246 (+39.0%) | 0.1% | $2.38 | -29.4% | COMMON STOCK | 02008G201 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| RNA | AVIDITY BIOSCIENCES INC | 11,372,829 | $495,514 | 5.0% | $27.49 | +135.0% | — | 05370A108 |
| — | AKERO THERAPEUTICS INC | 5,477,561 | $260,075 | 2.6% | $26.03 | — | — | 00973Y108 |
| — | MERUS N V | 2,025,277 | $190,680 | 1.9% | $34.07 | — | — | N5749R100 |
| DGX | QUEST DIAGNOSTICS INC | 250,000 | $47,645 | 0.5% | $170.08 | +7.0% | — | 74834L100 |
| LENZ | LENZ THERAPEUTICS INC | 863,389 | $40,217 | 0.4% | $20.79 | +40.2% | — | 52635N103 |
| DYN | DYNE THERAPEUTICS INC | 2,890,567 | $36,566 | 0.4% | $20.42 | -7.3% | — | 26818M108 |
| ABVX | ABIVAX SA | 350,000 | $29,715 | 0.3% | $84.90 | — | — | 00370M103 |
| GEHC | GE HEALTHCARE TECHNOLOGIES I | 393,500 | $29,552 | 0.3% | $83.06 | -6.2% | — | 36266G107 |
| ALEC | ALECTOR INC | 6,990,806 | $20,693 | 0.2% | $2.20 | -19.5% | — | 014442107 |
| CTMX | CYTOMX THERAPEUTICS INC | 3,461,500 | $11,042 | 0.1% | $1.61 | +135.7% | — | 23284F105 |
| PEPG | PEPGEN INC | 1,500,000 | $6,930 | 0.1% | $1.61 | +222.0% | — | 713317105 |
| ADGM | ADAGIO MED HLDGS INC | 209,361 | $406 | 0.0% | $4.76 | -75.1% | — | 00534B100 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| QURE | UNIQURE NV | 3,711,462 (-16.1%) | $88,815 (-65.6%) | 0.9% | $12.98 | +197.4% | SHS | N90064101 |
| SYK | STRYKER CORPORATION | 245,000 (-50.0%) | $86,110 (-52.5%) | 0.9% | $348.93 | +4.2% | COM | 863667101 |
| PTGX | PROTAGONIST THERAPEUTICS INC | 5,059,053 (-12.1%) | $441,858 (+15.6%) | 4.4% | $23.47 | +248.8% | COM | 74366E102 |
| ISRG | INTUITIVE SURGICAL INC | 101,228 (-50.0%) | $57,331 (-36.7%) | 0.6% | $553.02 | -3.7% | COM NEW | 46120E602 |
| RARE | ULTRAGENYX PHARMACEUTICAL IN | 3,000,139 (-7.9%) | $69,003 (-29.6%) | 0.7% | $40.76 | -19.3% | COM | 90400D108 |
| AXSM | AXSOME THERAPEUTICS INC | 888,001 (-20.6%) | $162,185 (+19.4%) | 1.6% | $56.00 | +149.3% | COM | 05464T104 |
| NTRA | NATERA INC | 1,500,000 (-25.0%) | $343,635 (+6.7%) | 3.4% | $42.76 | +387.8% | COM | 632307104 |
| CRVS | CORVUS PHARMACEUTICALS INC | 447,607 (-83.3%) | $3,447 (-82.5%) | 0.0% | $7.47 | +5.6% | COM | 221015100 |
| XGN | EXAGEN INC | 790,462 (-53.4%) | $4,806 (-74.2%) | 0.0% | $11.21 | -18.8% | COM | 30068X103 |
| CNTA | CENTESSA PHARMACEUTICALS PLC | 1,790,837 (-21.9%) | $44,789 (-19.4%) | 0.4% | $16.90 | — | SPONSORED ADS | 152309100 |
| BBNX | BETA BIONICS INC | 2,500,000 (-24.2%) | $76,175 (+16.2%) | 0.8% | $18.64 | +43.2% | COM | 08659B102 |
| TSHA | TAYSHA GENE THERAPIES INC | 16,398,297 (-32.7%) | $90,191 (+13.2%) | 0.9% | $1.88 | +158.9% | COM SHS | 877619106 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| MDGL | MADRIGAL PHARMACEUTICALS INC | 1,993,687 | $1,161,004 | 11.6% | $231.65 | +120.5% | COM | 558868105 |
| PTCT | PTC THERAPEUTICS INC | 7,746,415 | $588,418 | 5.9% | $38.50 | +88.8% | COM | 69366J200 |
| APGE | APOGEE THERAPEUTICS INC | 2,712,097 | $204,709 | 2.1% | $27.01 | +133.2% | COM | 03770N101 |
| ESTA | ESTABLISHMENT LABS HLDGS INC | 2,588,831 | $188,674 | 1.9% | $28.18 | +114.3% | COM | G31249108 |
| ARGX | ARGENX SE | 673,497 | $566,377 | 5.7% | $351.97 | — | SPONSORED ADR | 04016X101 |
| GH | GUARDANT HEALTH INC | 1,481,033 | $151,273 | 1.5% | $48.77 | +83.4% | COM | 40131M109 |
| PEN | PENUMBRA INC | 866,499 | $269,403 | 2.7% | $247.59 | +11.6% | COM | 70975L107 |
| ACAD | ACADIA PHARMACEUTICALS INC | 7,144,524 | $190,830 | 1.9% | $21.24 | +12.5% | COM | 004225108 |
| CYTK | CYTOKINETICS INC | 2,721,158 | $172,902 | 1.7% | $29.14 | +113.4% | COM NEW | 23282W605 |
| URGN | UROGEN PHARMA LTD | 4,543,895 | $106,418 | 1.1% | $14.29 | +51.8% | COM | M96088105 |
| OBIO | ORCHESTRA BIOMED HLDGS INC | 8,306,063 | $34,470 | 0.3% | $10.12 | -60.1% | COM | 68572M106 |
| MASI | MASIMO CORP | 683,294 | $88,869 | 0.9% | $166.52 | -14.0% | COM | 574795100 |
| CMPS | COMPASS PATHWAYS PLC | 8,757,390 | $60,426 | 0.6% | $3.33 | — | SPONSORED ADS | 20451W101 |
| JBIO | JADE BIOSCIENCES INC | 1,449,273 | $22,362 | 0.2% | $33.31 | -64.8% | COM NEW | 008064206 |
| IMCR | IMMUNOCORE HLDGS PLC | 4,869,798 | $169,031 | 1.7% | $43.23 | — | ADS | 45258D105 |
| CGEM | CULLINAN THERAPEUTICS INC | 1,705,960 | $17,657 | 0.2% | $19.93 | -54.7% | COM | 230031106 |
| AQST | AQUESTIVE THERAPEUTICS INC | 6,250,000 | $40,375 | 0.4% | $4.32 | +44.1% | COM | 03843E104 |
| CMPX | COMPASS THERAPEUTICS INC | 2,500,000 | $13,425 | 0.1% | $3.16 | +46.2% | COM | 20454B104 |
| NGNE | NEUROGENE INC | 1,362,456 | $28,067 | 0.3% | $34.49 | -27.8% | COM | 64135M105 |
| RCKT | ROCKET PHARMACEUTICALS INC | 17,687,772 | $62,084 | 0.6% | $17.75 | -80.7% | COM | 77313F106 |
| TEM | TEMPUS AI INC | 200,000 | $11,810 | 0.1% | $53.98 | +44.9% | CL A | 88023B103 |
| ALKS | ALKERMES PLC | 1,672,356 | $46,793 | 0.5% | $27.15 | +10.3% | SHS | G01767105 |
| HTFL | HEARTFLOW INC | 495,000 | $14,429 | 0.1% | $32.24 | -0.1% | COM | 42238D107 |
| PCSC | PERCEPTIVE CAP SOLUTIONS COR | 742,500 | $9,675 | 0.1% | $10.07 | +11.9% | CL A ORD SHS | G70077105 |
| LRMR | LARIMAR THERAPEUTICS INC | 3,125,000 | $11,906 | 0.1% | $3.75 | +3.7% | COM | 517125100 |
| TENX | TENAX THERAPEUTICS INC | 378,346 | $4,612 | 0.0% | $6.41 | +35.6% | COM NEW | 88032L605 |
| NBIX | NEUROCRINE BIOSCIENCES INC | 1,062,072 | $150,634 | 1.5% | $114.68 | +26.3% | COM | 64125C109 |
| OMDA | OMADA HEALTH INC | 200,000 | $3,156 | 0.0% | $17.31 | +17.2% | COM | 68170A108 |
| IMA | IMAGENEBIO INC | 334,445 | $2,308 | 0.0% | $13.25 | -44.1% | COM | 45175G207 |
| MIST | MILESTONE PHARMACEUTICALS IN | 2,506,102 | $5,062 | 0.1% | $20.06 | -89.3% | COM | 59935V107 |
| RCKTW | ROCKET PHARMACEUTICALS INC | 350,000 | $9 | 0.0% | $0.11 | — | *W EXP 09/02/202 | 77313F114 |